Statins × lipids

TrialJournal of the American College of Cardiology2011

Cardiovascular event reduction and adverse events among subjects attaining low-density lipoprotein cholesterol <50 mg/dl with rosuvastatin. The JUPITER trial (Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin).

Judith Hsia et al.PubMed ↗Publisher ↗

What the trial testedas reported · 16,304 people · 2011

Range includes no effect

No clear effect on lipids

−24%−43% to +0%

Bigger than 5 in 10 on the map

As reported

HR 0.76, 95% CI 0.57–1.00

One number in the abstract

the abstract, start to end

(fully-adjusted hazard ratio: 0.76; 95% confidence interval: 0.57

← favours treatmentfavours comparator →
could be chance
Lipids
HR 0.760.57–1.00
StatinsLipids

Statins × lipidshelps?mixed

unlikelylikely
0.500.50 without it
← favours comparatorfavours treatment →
this papermore certainless certain
1 / 5

79 papers cite itlatest 60 shown

2011
2012
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 21492764